GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio Preventive Medicine Corp (ROCO:6810) » Definitions » Additional Paid-In Capital

Bio Preventive Medicine (ROCO:6810) Additional Paid-In Capital : NT$233.12 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bio Preventive Medicine Additional Paid-In Capital?


Bio Preventive Medicine's quarterly additional paid-in capital increased from Dec. 2022 (NT$180.45 Mil) to Jun. 2023 (NT$233.12 Mil) but then stayed the same from Jun. 2023 (NT$233.12 Mil) to Dec. 2023 (NT$233.12 Mil).

Bio Preventive Medicine's annual additional paid-in capital increased from Dec. 2021 (NT$126.23 Mil) to Dec. 2022 (NT$180.45 Mil) and increased from Dec. 2022 (NT$180.45 Mil) to Dec. 2023 (NT$233.12 Mil).


Bio Preventive Medicine Additional Paid-In Capital Historical Data

The historical data trend for Bio Preventive Medicine's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Preventive Medicine Additional Paid-In Capital Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 63.47 122.84 126.23 180.45 233.12

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.23 180.36 180.45 233.12 233.12

Bio Preventive Medicine Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Bio Preventive Medicine Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bio Preventive Medicine's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Preventive Medicine (ROCO:6810) Business Description

Traded in Other Exchanges
N/A
Address
No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product.

Bio Preventive Medicine (ROCO:6810) Headlines

No Headlines